Many patients are surprised to learn that certain serious eye diseases may require intravenous (IV) treatment rather than eye drops or oral medications alone. Since infusion suites are uncommon in ophthalmology, patients often have questions about what they are and why they are used.
An ophthalmic infusion suite is a specialized medical setting designed to deliver advanced IV therapies for complex inflammatory eye diseases in a safe, closely monitored environment.
What Is an Ophthalmic Infusion Suite?
An ophthalmic infusion suite is a dedicated clinical space where patients receive IV medications to treat severe inflammatory and autoimmune eye diseases.
Unlike a standard exam room, infusion suites are equipped for:
-
- Medication administration
- Laboratory monitoring
- Ongoing patient observation
- Coordinated specialty treatment
Importantly, medications are delivered through an IV in the arm, rather than injected directly into the eye.
Why Would Eye Disease Require IV Therapy?
Some inflammatory eye conditions cannot be effectively controlled with eye drops, oral medications, or injections alone. In these cases, intravenous immunomodulatory therapy may help reduce inflammation and preserve long-term vision.
Conditions commonly treated with infusion therapy include:
-
- Uveitis
- Scleritis
- Ocular cicatricial pemphigoid
These conditions are often chronic autoimmune or inflammatory diseases that require highly specialized management.
Is Infusion Therapy for Eye Disease Chemotherapy?
One of the most common misconceptions about infusion therapy is that it involves cancer treatment.
In reality, ophthalmic infusion therapy uses immunomodulatory medications designed to control inflammation and regulate abnormal immune system activity affecting the eyes. These medications are not chemotherapy treatments for cancer.
What Medications Are Used?
Treatment plans are customized based on the patient’s diagnosis, medical history, and medication tolerability.
Common medications may include:
-
- Solu-Medrol
- Infliximab
- Rituximab
- Tocilizumab
- Teprotumumab
These therapies help suppress harmful inflammation that may otherwise threaten vision.
Why Are Ophthalmic Infusion Suites Rare?
Dedicated ophthalmic infusion suites are uncommon because most ophthalmology practices do not provide integrated infusion therapy onsite.
Patients frequently need to coordinate care between multiple specialists or external infusion centers. MERSI developed its infusion suite to provide a streamlined, one-location treatment experience for patients with complex inflammatory eye disease.
What Is an Ophthalmic Infusion Suite?
Patients throughout the Greater Boston area can access advanced ophthalmic infusion therapy at MERSI in Waltham.
Our integrated infusion suite combines specialized ophthalmology expertise, onsite laboratory testing, infusion monitoring, and coordinated treatment planning within one dedicated practice focused on preserving long-term vision.
FAQs
What is an ophthalmic infusion suite used for?
An ophthalmic infusion suite is used to administer IV medications for severe inflammatory and autoimmune eye diseases.
Are medications injected into the eye during infusion therapy?
No. Medications are administered intravenously through the arm.
Is infusion therapy chemotherapy?
No. Ophthalmic infusion therapy uses immunomodulatory medications to control inflammation, not cancer chemotherapy.
What conditions may require infusion therapy?
Conditions such as uveitis, scleritis, and ocular cicatricial pemphigoid may require IV treatment when other therapies are ineffective.
Is an ophthalmic infusion suite common?
No. Dedicated ophthalmic infusion suites are rare and typically only found within highly specialized ophthalmology practices.